DNA had massive bearish selloff and is trading at very low price just above HKEX:1 area. Between current lows and ATH, we can anticipate a decent rally before resuming a larger move lower (if that would happen in future). At these lows its great price range to accumulate and build a position using risk management and DCA strategy. It's been trading back it forth...
KRRO is in the biotechnology space in the gene-editing realm. It is in portfolios of C. Woods . A recent analyst gave it an upside to 100 which is very favorable given its product line and track record with an all-time high of about $250 ( which is about 450% over current valuation) On the one-hour time frame, it has had a great week and is breaking out over...
AT A GLANCE Simplistic Analysis </ Trend Analysis: +Fibonacci Retracement for the second time, outlining three areas of confluence. DNA Analysis: clusters of +Volatility provide expectations of another buy wave to form the +Fibonacci Retracement. Chart: the second retracement and buy arrow are drawn as an exact copy of the first.
If you haven`t bought DNA here: Then analyzing the options chain and the chart patterns of DNA Ginkgo Bioworks Holdings prior to the earnings report this week, I would consider purchasing the $2.50 strike price Calls with an expiration date of 2023-12-15, for a premium of approximately $0.32. If these options prove to be profitable prior to the earnings release,...
NYSE:DNA be ready for bio-world, bio-factory, biological food ingredients via cell programming! Advise yourself smartly!
A pretty compelling argument for a classic Wyckoff Accumulation pattern. We know some people like Woods are investing heavily into this market, so it's not a long shot to assume there are others. Whether we see a spring or LPS our way up to SOS is TBD, we could shoot in either direction as it stands. PTs are at $7-$15 according to analysts. This seems to line up...
$DNA Ginko Bioworks Sell exhaustion. Bullish divergence on weekly Target $2-$3
I just wanna share some of the things I worked on it's still incomplete, and still adding some of my analysis I used Wyckoff theory, pattern recognition(This cannot predict the future but it can help us define what can are the possible moves that btc will do) Observation : -Every 1st month of the day of 365 days before halvening, btc tends to show sos sign of...
DNA Ginkgo Bioworks Holdings is close to all time low on the lower end of a Falling Wedge. I think it`s primed for an imminent breakout. ARK Invest keeps buying it at this level. Looking at the DNA Ginkgo Bioworks Holdings options, I would buy the $2 strike price Calls with 2023-3-17 expiration date for about $0.20 premium. DNA Ginkgo Bioworks Holdings is one...
$ILMN gapped down Jan 20 190 P were selling for $7.3+ on gap down Risk reward worth, took stab #stocks #options - Up 50% in a few minutes But will hold $ILMN Puts, believe it goes higher Gap @ 204 On the chance we get put, doubt it, but in the chance, it's in a channel 180 - 240 - Daily in a nice channel
Earnings are coming out next week (14th), it could spark a run here on DNA. This is a great R:R swing trade, one of the best setups I could find recently.
We are currently in a long accumulation base and trading inside a wedge.
We are not in the business of getting every prediction right, no one ever does and that is not the aim of the game. The Fibonacci targets are highlighted in purple with invalidation in red. Fibonacci goals, it is prudent to suggest, are nothing more than mere fractally evident and therefore statistically likely levels that the market will go to. Having said that,...
Who else sees a perfect cup and handle formed here? Thoughts?
BNTC Benitec Biopharma Inc is a development-stage biotechnology company which focuses on the development of novel genetic medicines. The company develops DNA-directed RNA interference based therapeutics. BlackRock Inc., Renaissance Technologies LLC, Vanguard Group Inc. and Morgan Stanley have stakes in it. On 2/17/2022 P. Trucchio from HC Wainwright brokerage...
BTC Benitec Biopharma is sitting now at a key support from which we can expect a bounce. We know that earlier this year they had a 7.5mil offering price to the public of $4.25 per share and that Morgan Stanley has a 5.2% stake in the genetic drug company. Benitec's "proprietary platform, called DNA-directed RNA interference, or ddRNAi, combines RNA...
Quick Analysis on Ginkgo Bioworks Holdings, Inc. (DNA) on a 4H Linear Chart. This is an Ark Invest (Cathie Wood) portfolio name. 1) The stock price for DNA looks to be potentially forming a Head and Shoulders Pattern with the current Right Shoulder formation in process. 2) The Right Shoulder price target would be around $12-$12.25 using the Volume Profile (VPVR)...
DISCLAIMER This is in no way, shape or form, fluid and function, an analytical, qualitative or intelligent compte rendu. There is absolutely no financial advice here because the only financial advice I can give is to research, research, and research. The purpose of this analysis is to serve as an example of an investigation into a company's background,...